Foscarbidopa/foslevodopa
id:
foscarbidopa-foslevodopa-188-18070523
title:
Foscarbidopa/foslevodopa
text:
Foscarbidopa/foslevodopa, sold under the brand name Vyalev, is a fixed-dose combination medication used for the treatment of Parkinson's disease. It is a combination of prodrugs for levodopa and carbidopa that was developed by AbbVie. The combination was refused approval by the US Food and Drug Administration (FDA) in 2023. It was approved for medical use in Canada in May 2023, and in Australia in March 2024.
brand slug:
wiki
category slug:
encyclopedia
description:
Combination medication
original url:
https://en.wikipedia.org/wiki/Foscarbidopa/foslevodopa
date created:
2023-11-25T02:44:50Z
date modified:
2024-09-09T01:29:18Z
main entity:
{"identifier":"Q123575751","url":"https://www.wikidata.org/entity/Q123575751"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/0/01/Foscarbidopa.svg","width":685,"height":350}
fields total:
13
integrity:
16